Cumberland Pharmaceuticals Inc.

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Jazz Moves Into IO With Engineered IFN⍺

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. J&J Inks Partnerships With TRexBio, i2O

Here's your US drug review and approval news for the week in brief: Sandoz Inc. finally can take its turn to celebrate, as the Novartis AG unit scored a long-awaited approval for its biosimilar of

In scoring an approval for a Parkinson's disease indication, Kyowa Hakko Kirin Co. Ltd. 's Nourianz (istradefylline) became the ninth novel drug cleared by the Center for Drug Evaluation and Research